• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Neuroscience

The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next
  • collapse Rater-blind, prospective study comparing the effect of clozapine vs quetiapine for the treatment of psychosis ins parkinsonian patients.
  • collapse Efficacy, safety and cognitive function in patients with behavioural and psychologicall symptoms of dementia under tretment with Quetiapine in comparison to Risperidone.
  • collapse A non-comparative, open-label study to demonstrate the efficacy and tolerability of Quetiapine in adolescent patients with an acute schizophrenic episode.
  • collapse Quetiapine as add-on therapy in psychotic depression.
  • collapse Efficacy study of Quetiapine in the treatment of patients with cocaine dependence.
  • collapse The use of Quetiapine in patients with movement disorder
  • collapse Adjunctive Quetiapine administration to congenitive behaviour therapy in refractory depression: A twelwe week placebo controlled trial
  • collapse Study of the effects of Seroquel in patients with Borderline personality disorder.
  • collapse A functional magnetic resonance imaging study on the effect of an atypical antipsychotic (quetiapine) on blunted affect in schizophrenia.
  • expand Efficacy of Quetiapine compared to Risperidone on negative symptoms and cognition with regard to underlying neurobiological mechanisms and brain activation.
    Study Id
    5077/9007
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    5077/9007
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013